BioStem Technologies, Inc. (BSEM)
$0.00+$0.00 (+0.00%) Latest sessionExtended Hours
Mark A. Glickman - DirectorMark A. Glickman - DirectorBioStem Technologies Inc is a regenerative biotechnology company focused on harnessing elements of perinatal tissue and the body's innate biology to repair or reverse damage caused by a broad range of degenerative diseases. The company develops, manufactures, and sells tissue allografts for the wound care market with a focus on the treatment of diabetic, pressure, and venous ulcers. Utilizing its proprietary BioRetain processing method, it manufactures perinatal tissue allografts. The company offers a comprehensive portfolio of high-quality brands that are trademarked and include VENDAJE AC, AmnioWrap2, and Others. The company generates key revenue from VENDAJE AC.
https://www.biostemtechnologies.comSEC filings for BSEM on EDGAR
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Option exercise | 16 | 91,716 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
8 Form 4 filings on record, the earliest from Aug 20, 2026, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Barry Hassett - Officer | Option exercise | Common Stock | 500 | $0.00 | - | |
| Barry Hassett - Officer | Option exercise | Restricted Stock Units | 500 | $0.00 | - | |
| Jodi Ungrodt - Director | Option exercise | Common Stock | 5,647 | $0.00 | - | |
| Jodi Ungrodt - Director | Option exercise | Restricted Stock Units | 5,647 | $0.00 | - | |
| Mark A. Glickman - Director | Option exercise | Common Stock | 7,671 | $0.00 | - | |
| Mark A. Glickman - Director | Option exercise | Restricted Stock Units | 7,671 | $0.00 | - | |
| Hannaway Rayna Lesser - Director | Option exercise | Common Stock | 7,671 | $0.00 | - | |
| Hannaway Rayna Lesser - Director | Option exercise | Restricted Stock Units | 7,671 | $0.00 | - | |
| Kenneth Howard Warrington Jr. - Director | Option exercise | Common Stock | 5,094 | $0.00 | - | |
| Kenneth Howard Warrington Jr. - Director | Option exercise | Restricted Stock Units | 5,094 | $0.00 | - | |
| Steven D. Sonenreich - Director | Option exercise | Common Stock | 7,671 | $0.00 | - | |
| Steven D. Sonenreich - Director | Option exercise | Restricted Stock Units | 7,671 | $0.00 | - | |
| Brandon Poe - Officer | Option exercise | Common Stock | 10,634 | $0.00 | - | |
| Brandon Poe - Officer | Option exercise | Restricted Stock Units | 10,634 | $0.00 | - | |
| Michael A. Fortunato - Officer | Option exercise | Common Stock | 970 | $0.00 | - | |
| Michael A. Fortunato - Officer | Option exercise | Restricted Stock Units | 970 | $0.00 | - |
BioStem Technologies, Inc. (BSEM) had 8 insider filings in the last 90 days, with the most recent on 2026-09-11. The full record for BSEM runs to 8 Form 4 filings, the earliest from 2026-08-20. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of BSEM were filed in the last 90 days.
No insider sales of BSEM were filed in the last 90 days.
This page tracks BSEM Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add BSEM to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
